A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SOLIDIFIED BENZYL BENZOATE APPLIED IN DWELLINGS OF ASTHMATIC-PATIENTS SENSITIVE TO MITES - CLINICAL EFFICACY AND EFFECT ON MITE ALLERGENS
A. Dietemann et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SOLIDIFIED BENZYL BENZOATE APPLIED IN DWELLINGS OF ASTHMATIC-PATIENTS SENSITIVE TO MITES - CLINICAL EFFICACY AND EFFECT ON MITE ALLERGENS, Revue francaise d'allergologie et d'immunologie clinique, 34(4), 1994, pp. 354-362
Background: The aim of this double-blind, randomized study was to inve
stigate the effectiveness of an acaricidal cleaning product in modifyi
ng both clinical symptoms and mite allergen levels over a period of at
least 1 year. Methods: Twenty-six asthmatic patients with proven Derm
atophagoides pteronyssinus (Dp) asthma were selected; three were withd
rawn from the trial. The patients' homes were divided into two groups;
11 homes were treated with solidified benzyl benzoate and tenside age
nts (A), and 12 were treated with a placebo (P). Two applications were
performed at the beginning of the trial and at least 6 months later.
Patients were examined 1 month before the trial, at the beginning of t
he trial, and every 3 months over a period of 1 year. Indoor mite expo
sure was evaluated by three methods: semiquantitative guanine determin
ations, quantitative guanine determinations, and the measurement of De
r p I + Der f I (antigen P, of Dp + antigen F1 of D. farinae) levels.
Results: The symptom scores established at the beginning of the trial
and 12 months later showed a statistically significant improvement onl
y in the A group (p < 0.01). The visual analog scale also showed a sta
tistically significant difference both in the A (p < 0.05) and P group
s (p < 0.01). No statistical differences were found between medication
scores in the A or P groups. A statistically significant increase was
also observed for forced expiratory volume in 1 second and maximal ex
piratory flow rate 25/75 in the two groups (p < 0.05 for P group; p <
0.01 for A group). The mean decreases in Der p I + Der f I in patient
mattresses between the beginning of the trial and after 12 months were
20% for the acaricide group and 17% for the placebo group, respective
ly (NS). For house dust samples with origins other than the patients'
mattresses we found significant decreases in Der p I + Der f I in the
A group (p < 0.01 for carpets and p < 0.05 for upholstery elements).